Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide ...
Recall of Losartan Potassium Tablets, USP, 25 mg, 50 mg and 100 mg Due to the Detection of Trace Amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) Impurity found in the Active Pharmaceutical Ingredient (API) February 28, 2019 . Camber Pharmaceuticals, Inc. is recalling 87 lots of Losartan Tablets USP 25 mg, 50 mg, and 100 mg to consumer ... ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- camber pharmaceuticals recall of losartan
- recall of losartan by camber effective date february 28 2019
- the united states district court for the district of
- losartan potassium tablets
- fda recalls optumrx
- drug recall list blue cross blue shield of michigan
- legacy pharmaceutical packaging recall of losartan
- drug recall allways health partners
- camber pharmaceuticals inc issues voluntary nationwide
Related searches
- canadian pharmaceuticals online safe
- canadian pharmaceuticals online
- camber pharmaceuticals recalls
- canada pharmaceuticals online
- nationwide credit inc headquarters
- nationwide credit inc location
- nationwide credit inc reviews
- nationwide credit inc endicott ny
- lupin pharmaceuticals recall 2020
- gmp guidelines for pharmaceuticals pdf
- aurobindo pharmaceuticals recalls
- canadian pharmaceuticals online reviews